A Phase I Study of VEGF [Vascular endothelial growth factor] Trap [aflibercept] (NSC 724770, IND 100137) in Children With Refractory Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2013
At a glance
- Drugs Aflibercept (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 20 Jul 2012 Actual end date changed from Aug 2011 to Feb 2010 as reported by ClinicalTrials.gov.
- 11 Oct 2011 Actual end date changed from Feb 2010 to Aug 2011 as reported by ClinicalTrials.gov.
- 15 Dec 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.